Erste Asset Management GmbH »

Atrium Therapeutics shares owned by Erste Asset Management GmbH

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Erste Asset Management GmbH from 13F filings

Historical chart of Erste Asset Management GmbH investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Erste Asset Management GmbH consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Erste Asset Management GmbH

Quarter filed Position value Share count Share price at filing
2026-03-31 $49k 3.6k 13.55

More positions owned by Erste Asset Management GmbH

Gilead Sciences Common Stock (GILD)
Amphenol Corp Common Stock (APH)
Starbucks Corp Common Stock (SBUX)
Morgan Stanley Common Stock (MS)
Home Depot Common Stock (HD)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Alphabet Common Stock (GOOGL)
Ishares Gold Tr Fund/ETF (IAU)
Walmart Common Stock (WMT)
Amazon Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Common Stock (META)
Lam Research Corp Common Stock (LRCX)

View all positions for Erste Asset Management GmbH

Top funds holding Atrium Therapeutics

BlackRock
RA Capital Management
Vanguard Capital Management
TIG Advisors
Pentwater Capital Management
Sessa Capital IM
Goldman Sachs Group
Vanguard Portfolio Management
Geode Capital Management
683 Capital Management
Weiss Asset Management LP[1
Cantor Fitzgerald, L. P.
Balyasny Asset Management
Squarepoint Ops
Fort Hoosac Management

View all funds holding Atrium Therapeutics